{"organizations": [], "uuid": "e09fe1a7369162d5e82adeaa05b0313b43d6dfde", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180327.html", "section_title": "Archive News &amp; Video for Tuesday, 27 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/markets-swiss-stocks/swiss-stocks-factors-to-watch-on-march-27-idUSL8N1R85H5", "country": "US", "domain_rank": 408, "title": "Swiss stocks - Factors to watch on March 27", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-27T13:02:00.000+03:00", "replies_count": 0, "uuid": "e09fe1a7369162d5e82adeaa05b0313b43d6dfde"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/markets-swiss-stocks/swiss-stocks-factors-to-watch-on-march-27-idUSL8N1R85H5", "ord_in_thread": 0, "title": "Swiss stocks - Factors to watch on March 27", "locations": [], "entities": {"persons": [{"name": "milkybar", "sentiment": "none"}, {"name": "sensirion", "sentiment": "none"}, {"name": "julius baer", "sentiment": "none"}], "locations": [{"name": "zurich", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "abb", "sentiment": "none"}, {"name": "industrial solutions", "sentiment": "none"}, {"name": "novartis glaxosmithkline", "sentiment": "none"}, {"name": "nestle", "sentiment": "none"}, {"name": "ge", "sentiment": "none"}, {"name": "baloise", "sentiment": "none"}, {"name": "novartis", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "ZURICH, March 27 (Reuters) - The Swiss blue-chip SMI was seen opening 1.2 percent higher at 8,613 points on Tuesday, according to premarket indications by bank Julius Baer . Here are some of the main factors that may affect Swiss stocks.\nNOVARTIS GlaxoSmithKline will buy Novartis’s NOVN.S 36.5 percent stake in their consumer healthcare joint venture for $13.0 billion in cash, the partners said on Tuesday.\nFor more news, click on\nNESTLE The company is launching a lower-sugar Milkybar made with a new version of the sweetener which could help ease the $185 billion confectionery industry’s growing public health headache.\nFor more news, click on\nCOMPANY STATEMENTS * ABB said it has priced the $1.5 billion bond offering it has launched, with the funds being earmarked for general corporate purposes and a portion of its acquisition of GE’s Industrial Solutions business.\n* Sensirion said the over-allotment option has been fully exercised in its upcoming initial public offering.\n* Baloise reported full year profit attributable to shareholders up 2.5 percent at 548.0 million Swiss francs.\n* Novartis Chief Executive Vas Narasimhan aims to more than double the pharmaceutical company’s sales in China over the next five years and gain faster reimbursement for cutting-edge cancer drugs as the country speeds up approvals, Bloomberg reported.\n* Ypsomed said it has established its first subsidiary in Canada.\n* Schmolz + Bickenbach said it will propose Isabel Corinna Knauf as a new independent member of the board of directors at its AGM. Two current members Vladimir Polienko and Dr Heinz Schumacher will not stand for re-election.\n* Cassiopea, a clinical stage speciality pharmaceutical company focused on medical dermatology products, has announced the lists of candidates proposed for the board of directors at its AGM next month.\n* SHL Telemedicine reported full year net profit of $2.4 million. [SHLTN.S>]\n* Warteck Invest reported full year profit of 16.4 million Swiss francs.\n* Vifor Pharma said it has concluded a agreement with Zeria to market Veltassa in Japan.\nReporting by Zurich newsroom\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-03-27T13:02:00.000+03:00", "crawled": "2018-03-28T18:53:52.003+03:00", "highlightTitle": ""}